Loading: 100%
Hill-Rom Holdings, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 10,000 (as per Q2 2017)no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker HRCno data available
Financial year endsFY ends End of Septemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 175060708090
datesClosing price (adj.)
13.10.201777.84
11.10.201777.17
04.10.201776.92
27.09.201774.13
20.09.201772.79
13.09.201777.39
06.09.201776.57
30.08.201775.14
23.08.201773.16
16.08.201774.70
09.08.201774.11
02.08.201774.98
26.07.201782.39
19.07.201783.28
12.07.201782.95
05.07.201780.37
27.06.201778.73
20.06.201780.00
13.06.201778.64
06.06.201778.31
30.05.201776.40
23.05.201774.91
16.05.201772.88
09.05.201775.13
02.05.201775.95
25.04.201772.40
18.04.201769.75
11.04.201770.75
04.04.201770.21
28.03.201770.05
21.03.201768.82
14.03.201767.32
07.03.201765.08
28.02.201765.97
21.02.201764.70
14.02.201761.62
07.02.201759.93
31.01.201758.45
24.01.201759.50
17.01.201759.71
10.01.201758.21
03.01.201756.43
27.12.201656.76
19.12.201654.69
12.12.201655.52
05.12.201653.52
28.11.201654.09
21.11.201654.86
14.11.201653.81
07.11.201658.82
31.10.201654.84
24.10.201659.08
17.10.201658.93
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
77.84n/a
Market Capitalisation
in million USD
5,119n/a
Enterprise Value
in million USD
7,044n/a
Common Shares Outstanding
as per Apr 24, 2017
65,766,800n/a
Preferred Shares Outstanding
as per Apr 24, 2017
n/a
Average Basic Shares Outstanding
TTM
65,432,500n/a
Average Diluted Shares Outstanding
TTM
66,960,500n/a
Index Membership
n/a
Business Summary
Hill-Rom Holdings Inc is engaged in selling and renting patient support and near-patient technologies and services, and health information technology solutions in the U.S. and Canada.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 2,655n/a
Gross Profit 1,257n/a
Operating Income 270n/a
EBITDA 383n/a
Net Profit 124n/a
Balance Sheet
Cash and Cash Equivalents 232n/a
Receivables 0n/a
Total Current Assets 1,082n/a
PP&E 350n/a
Total Assets 4,262n/a
Accounts Payable 136n/a
Current Debt 210n/a
Total Current Liabilities 662n/a
Long-Term Debt 1,938n/a
Total Liabilities 3,027n/a
Total Equity 1,236n/a
Cash Flow
Depreciation & Amortisation 113n/a
Change in Working Capital -42n/a
Operating Cash Flow 281n/a
Net Change in PP&E and Intangibles -71n/a
Investing Cash Flow -98n/a
Dividends Paid -44n/a
Financing Cash Flow -142n/a
Total Change in Cash 39n/a
Free Cash Flow 255n/a
Profitability Ratios
Gross Margin 47.3%n/a
Operating Margin 10.2%n/a
Net Profit Margin 4.6%n/a
Return on Equity 9.9%n/a
Return on Assets 2.9%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 18.38n/a
EV/Sales 2.65n/a
Book to Market Value 0.24n/a
Other Ratios
Current Ratio 163.4%n/a
Liabilities to Equity Ratio 244.9%n/a
Debt to Assets Ratio 50.4%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
1,508
1,387
1,470
1,592
1,634
1,716
1,686
1,988
2,655
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-838
-759
-753
-810
-880
-936
-906
-1,108
-1,398
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
670
628
717
781
755
780
780
880
1,257
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-544
-517
-533
-566
-563
-620
-620
-756
-987
Selling, General & Administrative
-487
-462
-475
-502
-496
-550
-548
-664
-853
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-57
-56
-58
-64
-67
-70
-72
-92
-134
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
126
111
184
216
191
161
160
124
270
Non-Operating Income (Loss)
-11
-6
-9
-7
-5
-11
-7
-18
-81
Interest Expense, net
-14
-10
-9
-9
-7
-10
-10
-18
-90
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
4
4
0
1
1
-1
2
0
9
Pretax Income (Loss), Adjusted
115
104
175
208
186
150
152
106
189
Abnormal Gains (Losses)
-23
-483
8
-49
-23
-6
-37
-41
-51
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
92
-379
183
160
164
144
115
65
138
Income Tax (Expense) Benefit, net
-25
-26
-57
-26
-43
-39
-55
-18
-16
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
67
-405
126
134
121
105
61
47
123
Net Extraordinary Gains (Losses)
49
0
0
0
0
0
0
0
0
Discontinued Operations
49
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
116
-405
126
134
121
105
61
47
123
Minority Interest
0
0
-1
0
0
0
0
1
1
Net Income
116
-405
125
133
121
105
61
48
124
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
116
-405
125
133
121
105
61
48
124
Remarks
restated on Nov 17, 2010 n/a
calculated values,
restated on Nov 16, 2011 n/a
calculated values,
restated on Nov 15, 2012 n/a
calculated values,
restated on Nov 20, 2013 n/a
calculated values,
restated on Nov 19, 2014 n/a
calculated values,
restated on Nov 19, 2015 n/a
calculated values,
restated on Nov 17, 2016 n/a
calculated values,
restated on Nov 17, 2016 n/a
calculated values,
restated on Nov 17, 2016 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
197
185
225
84
127
99
193
232
Cash & Cash Equivalents
n/a
171
185
225
84
127
99
193
232
Short Term Investments
n/a
26
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
347
353
386
393
362
411
495
515
Accounts Receivable, Net
n/a
0
0
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
92
109
96
127
118
176
267
252
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
60
93
85
78
81
93
186
83
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
46
40
43
49
48
41
77
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
14
53
42
29
32
52
109
83
Total Current Assets
n/a
695
739
792
682
688
779
1,141
1,082
Property, Plant & Equipment, Net
n/a
272
244
223
250
234
262
378
350
Property, Plant & Equipment
n/a
821
805
820
835
822
850
976
962
Accumulated Depreciation
n/a
-549
-561
-597
-585
-587
-588
-598
-612
Long Term Investments & Receivables
n/a
17
12
11
7
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
248
251
274
688
665
711
2,938
2,830
Intangible Assets
n/a
142
137
126
291
253
261
1,248
1,143
Goodwill
n/a
73
81
87
335
343
400
1,611
1,584
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
34
39
38
23
22
43
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
33
33
26
24
32
27
58
60
Total Noncurrent Assets
n/a
538
506
507
946
899
972
3,317
3,180
Total Assets
n/a
1,233
1,246
1,299
1,628
1,587
1,751
4,458
4,262
Liabilities and owners' equity
Payables & Accruals
n/a
175 175200000
170 169500000
158 157500000
154 154100000
173 173200000
209 209000000
342 341800000
304 303800000
Accounts Payable
n/a
81 81300000
81 80600000
65 64800000
81 80700000
81 80800000
113 112700000
136 136300000
136 136000000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
94 93900000
89 88900000
93 92700000
73 73400000
92 92400000
96 96300000
206 205500000
168 167800000
Short Term Debt
n/a
102 102200000
53 53100000
100 100300000
115 115200000
81 81200000
127 126900000
58 58000000
210 210100000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
67 66900000
66 66100000
76 76200000
109 108800000
91 91000000
106 106400000
179 179000000
148 148400000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
67 66900000
66 66100000
76 76200000
109 108800000
91 91000000
106 106400000
179 179000000
148 148400000
Total Current Liabilities
n/a
344 344300000
289 288700000
334 334000000
378 378100000
345 345400000
442 442300000
579 578800000
662 662300000
Long Term Debt
n/a
100 99700000
99 98500000
51 50800000
238 237500000
226 225800000
364 364100000
2,175 2175200000
1,938 1938400000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
179 179300000
143 142600000
173 172600000
199 199400000
157 156900000
138 138400000
547 546700000
426 425800000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
101 100700000
59 59000000
87 87400000
90 89600000
53 52600000
77 76900000
119 118800000
99 99000000
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
17 16800000
31 31300000
36 36200000
68 68100000
67 67000000
31 31000000
381 380600000
288 287800000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
62 61800000
52 52300000
49 49000000
42 41700000
37 37300000
31 30500000
47 47300000
39 39000000
Total Noncurrent Liabilities
n/a
279 279000000
241 241100000
223 223400000
437 436900000
383 382700000
503 502500000
2,722 2721900000
2,364 2364200000
Total Liabilities
n/a
623 623300000
530 529800000
557 557400000
815 815000000
728 728100000
945 944800000
3,301 3300700000
3,027 3026500000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
123 123400000
124 123700000
119 118500000
121 121200000
127 127100000
139 138500000
566 566400000
580 580300000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-559 -559400000
-558 -558000000
-608 -607600000
-631 -630900000
-707 -706500000
-758 -757700000
-789 -788600000
-774 -773700000
Retained Earnings
n/a
1,105 1105200000
1,204 1203600000
1,310 1309800000
1,400 1400300000
1,474 1473800000
1,500 1499800000
1,510 1509900000
1,590 1589700000
Other Equity
n/a
-60 -59900000
-62 -61800000
-79 -79000000
-78 -78000000
-36 -35700000
-74 -74100000
-141 -140800000
-169 -169100000
Equity Before Minority Interest
n/a
609 609300000
708 707500000
742 741700000
813 812600000
859 858700000
807 806500000
1,147 1146900000
1,227 1227200000
Minority Interest
n/a
0 0
8 8300000
0 0
0 0
0 0
0 0
10 10000000
9 8700000
Total Equity
n/a
609 609300000
716 715800000
742 741700000
813 812600000
859 858700000
807 806500000
1,157 1156900000
1,236 1235900000
Total Liabilities & Equity
n/a
1,233 1232600000
1,246 1245600000
1,299 1299100000
1,628 1627600000
1,587 1586800000
1,751 1751300000
4,458 4457600000
4,262 4262400000
Remarks restated on n/a restated on Nov 17, 2010 n/a restated on Nov 16, 2011 n/a restated on Nov 15, 2012 n/a restated on Nov 20, 2013 n/a restated on Nov 19, 2014 n/a restated on Nov 19, 2015 n/a restated on Nov 17, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
116
-405
126
134
121
105
61
47
123
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
113
100
100
104
95
89
78
84
113
Non-Cash Items
22
471
-41
-20
3
28
58
43
88
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
20
60
-45
5
43
42
14
40
-42
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
271
226
140
223
262
263
210
214
281
Change in Fixed Assets & Intangibles
-102
-49
-62
-63
-67
-59
-60
-120
-71
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
344
2
31
1
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
-187
-7
-16
-477
0
-240
-1,639
-25
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-298
0
0
0
5
1
5
2
-2
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-56
-234
-38
-78
-540
-59
-295
-1,756
-98
Dividends Paid
-48
-26
-26
-27
-30
-31
-34
-37
-44
Cash From (Repayment of) Debt
25
-26
-45
0
210
-45
158
1,778
-101
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
15
1
-11
-69
-34
-84
-58
-48
2
Increase in Capital Stock
17
1
26
46
11
10
14
15
10
Decrease in Capital Stock
-1
-1
-37
-115
-44
-94
-72
-63
-8
Other Financing Activities
-55
5
-5
-5
-11
-1
-2
-49
1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-64
-45
-87
-102
136
-162
64
1,643
-142
Net Cash Before Disc. Operations and FX
150
-54
14
43
-142
43
-20
100
42
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
150
-54
14
43
-142
43
-20
100
42
Effect of Foreign Exchange Rates
-10
3
0
-3
2
0
-8
-7
-2
Net Changes in Cash
140
-51
14
40
-140
43
-28
94
39
Remarks
restated on Nov 17, 2010 n/a
calculated values,
restated on Nov 16, 2011 n/a
calculated values,
restated on Nov 15, 2012 n/a
calculated values,
restated on Nov 20, 2013 n/a
calculated values,
restated on Nov 19, 2014 n/a
calculated values,
restated on Nov 19, 2015 n/a
calculated values,
restated on Nov 17, 2016 n/a
calculated values,
restated on Nov 17, 2016 n/a
calculated values,
restated on Nov 17, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo